Trial Profile
Multi-center,Randomized,Double Blind,Placebo Controlled,Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Hyzetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Zhejiang Hisun Pharmaceutical
- 17 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Jan 2018 New trial record